Rankings
▼
Calendar
SCYX Q1 2016 Earnings — SCYNEXIS, Inc. Revenue & Financial Results | Market Cap Arena
SCYX
SCYNEXIS, Inc.
$37M
Q1 2016 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$64,000
Gross Profit
$64,000
100.0% margin
Operating Income
-$7M
-11268.8% margin
Net Income
-$7M
-11225.0% margin
EPS (Diluted)
$-5.17
Cash Flow
Operating Cash Flow
-$9M
Free Cash Flow
-$9M
Stock-Based Comp.
$274,000
Balance Sheet
Total Assets
$41M
Total Liabilities
$6M
Stockholders' Equity
$35M
Cash & Equivalents
$38M
← FY 2016
All Quarters
Q2 2016 →